Results 121 to 130 of about 1,398,102 (297)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Discovery of multi-target anti-gout agents from Eurycoma longifolia Jack through phenotypic screening and structural optimization

open access: yesNature Communications
Developing anti-gout medications that simultaneously reduce uric acid and exert anti-inflammatory effects represents a critical breakthrough for managing gout progression.
Zhijiao Zhang   +25 more
doaj   +1 more source

Revolutionizing Antibiotics: Breakthroughs in Discovery and Development

open access: yesJournal of Medical Pharmaceutical and Allied Sciences
Antibiotics are chemical substances that inhibit the growth of bacteria and other microbes. Antibiotics should cause minimal or no toxicity and should be effective against a particular infection. The early era of 1940-1960s is considered as golden age of antibiotics.
openaire   +1 more source

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

ACHIEVING SUCCESSFUL IMPLEMENTATION OF IMPROVEMENT PROJECTS IN ELDERLY CARE ORGANIZATIONS IMPLEMENTATION OF BREAKTHROUGH PROJECTS IN SPECIAL ACCOMMODATIONS FOR ELDERLY [PDF]

open access: yes, 2005
Recent innovations in the medical field improve the opportunities to treat diseases and injuries better, even at an advanced age. In addition, the Swedish population is reported as growing steadily older. In order to cope with those challenges, Swedish
Kostak, Esra, Lobaiko, Viktoria
core   +1 more source

Applications of artificial intelligence in cancer immunotherapy: a frontier review on enhancing treatment efficacy and safety

open access: yesFrontiers in Immunology
Cancer immunotherapy represents a major breakthrough in oncology, particularly with immune checkpoint inhibitors (ICIs) and CAR-T cell therapies. Despite improved outcomes, challenges such as immune-related adverse events (irAEs) and treatment resistance
Ji’an Liu   +8 more
doaj   +1 more source

Prelude to, and Nature of the Space Photometry Revolution

open access: yesEPJ Web of Conferences, 2015
It is now less than a decade since CoRoT initiated the space photometry revolution with breakthrough discoveries, and five years since Kepler started a series of similar advances.
Gilliland Ronald L.
doaj   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Discoveries and Breakthroughs Inside Science [PDF]

open access: yesJournal of Undergraduate Materials Research, 2008
Lane W. Martin   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy